12:00 AM
 | 
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Inception Sciences, Roche deal

Roche, Versant Ventures and drug discovery company Inception Sciences launched Inception 3 Inc. to discover treatments for sensorineural hearing loss. The newco, which has a license to undisclosed IP from Stanford University, plans to develop therapies that target inner ear hair cell protection and regeneration in the cochlea. Versant will provide equity financing, and...

Read the full 277 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >